Impact Factor: 7.883
Submit Paper
Volume 4, Issue 3 (March 2018)

Drug Profile Of Ivacaftor And Lumacaftor

Impact Factor
7.883
Call For Paper
Volume 12 Issue 07

July 2026

Download Paper Format
Copyright Form
Share on:

Author(s)

N.MD.Akram (Research Scholar) Dr. M. Umamahesh

Abstract

Ivacaftor And Lumacaftor Are Vocally Available In The Form Of Correctors Of The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) That Are Used To Care For Patients With Cystic Fibrosis With Specific Mutations Of The CFTR. Ivacaftor Alone Or In


Keywords

Ivacaftor And Lumacaftor Cystic Fibrosis Transmembrane Conductance Regulator.

Paper ID

IJSARTV4I321446

Publication Date

March 14, 2018

Research Area

Chemistry

Submit Your Paper to IJSART

Join the global research community with IJSART. Submit your paper, share your work, and gain worldwide recognition!